cyclosporine and Bilharziasis

cyclosporine has been researched along with Bilharziasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, H; Liu, M; Wang, S; Xiang, T; Yang, K; Zhang, XL; Zhou, YD1
El-Agroudy, AE; Ghoneim, MA; Ismail, AM; Nassar, M2
Arunan, K; Bluestone, JA; Sciammas, R; Sperling, AI; Tatsumi, Y1

Reviews

1 review(s) available for cyclosporine and Bilharziasis

ArticleYear
TCR gamma delta cells: mysterious cells of the immune system.
    Immunologic research, 1994, Volume: 13, Issue:4

    Topics: Animals; Antigen Presentation; Arthritis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Collagen; Cyclosporine; Humans; Listeriosis; Mice; Mice, Transgenic; Models, Immunological; Receptors, Antigen, T-Cell, gamma-delta; Schistosomiasis; Thy-1 Antigens

1994

Trials

2 trial(s) available for cyclosporine and Bilharziasis

ArticleYear
Cyclosporine therapeutic monitoring with C(MAX) in kidney transplant recipients: racial considerations.
    Clinical and experimental nephrology, 2009, Volume: 13, Issue:2

    Topics: Adult; Cohort Studies; Cyclosporine; Drug Monitoring; Egypt; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Schistosomiasis

2009
Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2008, Volume: 6, Issue:4

    Topics: Adult; Cyclosporine; Drug Monitoring; Egypt; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Middle Aged; Models, Biological; Predictive Value of Tests; Reproducibility of Results; Schistosomiasis

2008

Other Studies

1 other study(ies) available for cyclosporine and Bilharziasis

ArticleYear
An iminosugar N-pentafluorobenzyl-1-deoxynojirimycin as a novel potential immunosuppressant for the treatment of Th2-related diseases.
    Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

    Topics: 1-Deoxynojirimycin; Animals; Benzyl Compounds; CD4-Positive T-Lymphocytes; Chemistry, Pharmaceutical; Cyclosporine; Cytoplasm; Drug Design; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-4; Leukocytes, Mononuclear; Mice; Models, Chemical; Schistosoma japonicum; Schistosomiasis; Signal Transduction; Spleen; Th2 Cells; Time Factors

2012